Impact of Certolizumab Pegol on Patient‐Reported Outcomes in Patients With Axial Spondyloarthritis

by Sieper, J., Kivitz, A., van Tubergen, A., Deodhar, A., Coteur, G., Woltering, F., Landewé, R.
Published 2015

Observed Incidence of Uveitis Following Certolizumab Pegol Treatment in Patients With Axial Spondyloarthritis

by Rudwaleit, M., Rosenbaum, J. T., Landewé, R., Marzo‐Ortega, H., Sieper, J., van der Heijde, D., Davies, O., Bartz, H., Hoepken, B., Nurminen, T., Deodhar, A.
Published 2016

Treating axial and peripheral spondyloarthritis, including psoriatic arthritis, to target: results of a systematic literature search to support an international treat-to-target rec...

by Schoels, M M, Braun, J, Dougados, M, Emery, P, Fitzgerald, O, Kavanaugh, A, Kvien, T K, Landewé, R, Luger, T, Mease, P, Olivieri, I, Reveille, J, Ritchlin, C, Rudwaleit, M, Sieper, J, Smolen, J S, de Wit, M, van der Heijde, D
Published 2014

Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled Ph...

by Landewé, R, Braun, J, Deodhar, A, Dougados, M, Maksymowych, W P, Mease, P J, Reveille, J D, Rudwaleit, M, van der Heijde, D, Stach, C, Hoepken, B, Fichtner, A, Coteur, G, de Longueville, M, Sieper, J
Published 2014

Features of the Synovium of Individuals at Risk of Developing Rheumatoid Arthritis: Implications for Understanding Preclinical Rheumatoid Arthritis

by de Hair, MJH, van de Sande, MGH, Ramwadhdoebe, TH, Hansson, M, Landewé, R, van der Leij, C, Maas, M, Serre, G, van Schaardenburg, D, Klareskog, L, Gerlag, DM, van Baarsen, LGM, Tak, PP
Published 2014

Signal intensity loss of the intervertebral discs in the cervical spine of young patients on fluid sensitive sequences

by de Bruin, F., ter Horst, S., van den Berg, R., de Hooge, M., van Gaalen, F., Fagerli, K. M., Landewé, R., van Oosterhout, M., Bloem, J. L., van der Heijde, D., Reijnierse, M.
Published 2015

Effect of certolizumab pegol over 96 weeks in patients with psoriatic arthritis with and without prior antitumour necrosis factor exposure

by Mease, P, Deodhar, A, Fleischmann, R, Wollenhaupt, J, Gladman, D, Leszczyński, P, Vitek, P, Turkiewicz, A, Khraishi, M, FitzGerald, O, Landewé, R, de Longueville, M, Hoepken, B, Peterson, L, van der Heijde, D
Published 2015

Effect of Certolizumab Pegol Over Ninety-Six Weeks in Patients With Axial Spondyloarthritis: Results from a Phase III Randomized Trial

by Sieper, J, Landewé, R, Rudwaleit, M, van der Heijde, D, Dougados, M, Mease, P J, Braun, J, Deodhar, A, Kivitz, A, Walsh, J, Hoepken, B, Nurminen, T, Maksymowych, W P
Published 2015